Evidence for post-translational incorporation of a product of mevalonic acid into Swiss 3T3 cell proteins
- PMID: 6565705
Evidence for post-translational incorporation of a product of mevalonic acid into Swiss 3T3 cell proteins
Abstract
Previous studies have identified several cellular requirements for mevalonic acid that appear unrelated to cholesterol, dolichol, or ubiquinone. To search for other products of mevalonic acid that might account for these requirements we cultured Swiss 3T3 cells in the presence of mevinolin, an inhibitor of mevalonic acid biosynthesis, then labeled the cells with exogenous radioactive mevalonic acid. Upon analyzing the radioactive material formed, we found that 40-50% of it was not extractable into lipid solvents, and that most of the lipid-insoluble material behaved like protein when treated with sodium dodecyl sulfate:chloroform:phenol, RNase, or proteinase K. Further analysis by electrophoresis revealed that radioactivity was associated with a few specific proteins that had apparent molecular weights of 13,000-58,000. Control experiments indicated that authentic radioactive (R)-mevalonic acid was the active precursor. Other lines of evidence suggested that mevalonate was first converted to an isoprenoid compound, then covalently incorporated into proteins by way of a cycloheximide-insensitive mechanism. These results suggest that Swiss 3T3 cells possess novel metabolic products of mevalonic acid metabolism that are formed by post-translational incorporation of isoprenoids into specific cell proteins.
Similar articles
-
A study of the Influence of mevalonic acid and its metabolites on the morphology of swiss 3T3 cells.J Cell Biol. 1982 Oct;95(1):144-53. doi: 10.1083/jcb.95.1.144. J Cell Biol. 1982. PMID: 7142283 Free PMC article.
-
Post-translational isoprenylation of cellular proteins is altered in response to mevalonate availability.J Biol Chem. 1989 Jun 15;264(17):9945-52. J Biol Chem. 1989. PMID: 2722887
-
Insensitivity of ubiquinone biosynthesis in glioblastoma cells to an epileptogenic drug, U18666A.J Neurochem. 1984 Nov;43(5):1409-14. doi: 10.1111/j.1471-4159.1984.tb05401.x. J Neurochem. 1984. PMID: 6567656
-
Cholesterol and mevalonic acid modulation in cell metabolism and multiplication.Toxicol Lett. 1992 Dec;64-65 Spec No:1-15. doi: 10.1016/0378-4274(92)90167-i. Toxicol Lett. 1992. PMID: 1471162 Review.
-
Pharmacology of competitive inhibitors of HMG-CoA reductase.Pharmacol Res. 1995 Jan;31(1):9-27. doi: 10.1016/1043-6618(95)80042-5. Pharmacol Res. 1995. PMID: 7784310 Review. No abstract available.
Cited by
-
Defective macromolecule biosynthesis and cell-cycle progression in a mammalian cell starved for mevalonate.Proc Natl Acad Sci U S A. 1985 May;82(10):3257-61. doi: 10.1073/pnas.82.10.3257. Proc Natl Acad Sci U S A. 1985. PMID: 2582409 Free PMC article.
-
Incorporation of a product of mevalonic acid metabolism into proteins of Chinese hamster ovary cell nuclei.J Cell Biol. 1988 Oct;107(4):1307-16. doi: 10.1083/jcb.107.4.1307. J Cell Biol. 1988. PMID: 3170631 Free PMC article.
-
Activation of polyisoprenyl diphosphate phosphatase 1 remodels cellular presqualene diphosphate.Biochemistry. 2009 Apr 7;48(13):2997-3004. doi: 10.1021/bi8020636. Biochemistry. 2009. PMID: 19220020 Free PMC article.
-
Inhibition of chronic pancreatitis and pancreatic intraepithelial neoplasia (PanIN) by capsaicin in LSL-KrasG12D/Pdx1-Cre mice.Carcinogenesis. 2011 Nov;32(11):1689-96. doi: 10.1093/carcin/bgr191. Epub 2011 Aug 22. Carcinogenesis. 2011. PMID: 21859833 Free PMC article.
-
Working together: Farnesyl transferase inhibitors and statins block protein prenylation.Mol Cell Pharmacol. 2009 Jan 1;1(1):1-6. doi: 10.4255/mcpharmacol.09.01. Mol Cell Pharmacol. 2009. PMID: 20419048 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources